Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: The Business Research Company | PRODUCT CODE: 1526827

Cover Image

PUBLISHER: The Business Research Company | PRODUCT CODE: 1526827

Small Volume Parenteral Global Market Report 2024

PUBLISHED:
PAGES: 175 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
PDF (Single User License)
USD 5000
PDF (Site License)
USD 7500
PDF (Enterprise License)
USD 10000

Add to Cart

Small volume parenteral (SVP) relates to a classification of sterile pharmaceuticals designed for parenteral delivery (circumventing the gastrointestinal tract) and usually dispensed in volumes of 100 milliliters (mL) or smaller. These items serve diverse medical functions, such as administering medications, vaccines, or biological therapies directly into the body via intravenous (IV), intramuscular (IM), or subcutaneous (SC) routes.

The primary categories of small volume parenteral include ampules, vials, and prefilled syringes. Ampules are compact, sealed containers utilized for storing and protecting liquid medications, typically opened by breaking off the neck. Available in single or multiple doses, they are employed to address diverse conditions such as pain management, cancer treatment, malnutrition, gastrointestinal issues, diabetes, among others. Widely used in local anesthetics, vaccines, and similar applications, they cater to various end users including hospitals, clinics, ambulatory surgical centers, and others.

The small volume parenteral market research report is one of a series of new reports from The Business Research Company that provides small volume parenteral market statistics, including small volume parenteral industry global market size, regional shares, competitors with a small volume parenteral market share, detailed small volume parenteral market segments, market trends and opportunities, and any further data you may need to thrive in the small volume parenteral industry. This small volume parenteral market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The small volume parenteral market size has grown strongly in recent years. It will grow from 163.34 billion in 2023 to $177.26 billion in 2024 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to the regulatory approvals and government initiatives, rising prevalence of chronic diseases, pharmaceutical outsourcing trends, and globalization and expansion of pharmaceutical markets.

The small volume parenteral market size is expected to see strong growth in the next few years. It will grow to $247.53 billion in 2028 at a compound annual growth rate (CAGR) of 8.7%. The anticipated growth in the forecast period can be credited to several factors, including the expansion of the biologics market, improvements in healthcare infrastructure, heightened rates of hospitalization, regulatory clearances, a trend towards home healthcare, augmented investments in healthcare, and the impact of global health crises. Significant trends expected during this period encompass the rise of biocompatible formulations, patient-centered strategies, the increasing prominence of home healthcare, advancements in manufacturing automation, diversification in therapeutic domains, and the emergence of smart pump technologies.

The rising frequency of surgical procedures is anticipated to drive the expansion of the small-volume parenteral market in the future. Surgery, a medical discipline focused on utilizing operative methods to diagnose or treat various pathological conditions, enhance bodily function or aesthetics, and mend damaged tissues, is witnessing an uptick in rates owing to advancements in medical technology and the aging populace, thus amplifying the demand for surgical interventions. Small-volume parenteral solutions play a vital role in surgeries by precisely delivering medications, electrolytes, and nutrients directly into the bloodstream. For example, data from the American Academy of Facial Plastic and Reconstructive Surgery in February 2022 revealed that approximately 1.4 million surgical and non-surgical plastic procedures were conducted in 2021, with plastic surgeons averaging 600 more procedures than in 2020. Hence, the escalating number of surgeries is fostering the growth of the small-volume parenteral market.

Key players in the small volume parenteral market are directing their efforts towards the development of innovative solutions, exemplified by Pharmatec SVP process systems, aimed at optimizing their market revenues. Pharmatec SVP process systems represent specialized solutions engineered to manufacture small-volume parenteral (SVP) pharmaceuticals. These systems are meticulously crafted to adhere to the rigorous demands of sterile manufacturing processes, ensuring elevated standards of quality and safety for injectable products. For instance, in March 2021, Syntegon, a German-based machinery industry leader, introduced the SVP Essential, a small-volume parenteral pharmaceutical production system engineered for both cost-effectiveness and superior quality. This system provides a fully automated, pre-configured solution, boasting the highest hygienic standards and ensuring process reproducibility. Particularly suited for the production of straightforward parenteral medications such as analgesics, insulin, and generic drugs, its modular design allows for delivery in a mere six months.

In February 2024, Eris Lifesciences Ltd., a pharmaceutical firm headquartered in India, acquired a majority stake of 51% in Swiss Parenteral for $76.52 million. This strategic move by Eris enhances its footprint in the sterile injectables sector and aligns with its strategy of targeting emerging markets. Swiss Parenteral, also based in India, specializes in the production of small-volume liquid parenteral formulations within the pharmaceutical industry.

Major companies operating in the small volume parenteral market are Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, Novartis AG, GlaxoSmithKline plc, Eli Lilly and Company, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Fresenius Kabi AG, Sun Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Viatris Inc, Intas Pharmaceuticals Ltd., Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, Lupin Limited, Biocon Limited, Torrent Pharmaceuticals Ltd., Zydus Cadila, Alembic Pharmaceuticals Ltd., Wockhardt Ltd.

North America was the largest region in the small volume parenteral market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the small volume parenteral market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the small volume parenteral market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The small volume parenteral market consists of sales of epinephrine, insulin, heparin, morphine, and vaccines. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Small Volume Parenteral Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on small volume parenteral market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for small volume parenteral ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The small volume parenteral market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Ampules; Vials; Prefilled Syringes
  • 2) By Dose Type: Single Dose; Multiple Dose
  • 3) By Indication Type: Pain Management; Cancer Care; Malnourishment; Gastrointestinal Disorder Or Diarrhea; Diabetes; Other Indications
  • 4) By Application: Local Anesthetics; Vaccines; Other Applications
  • 5) By End User: Hospitals; Clinics; Ambulatory Surgical Center; Other End Users
  • Companies Mentioned: Pfizer Inc.; AbbVie Inc.; Bayer AG; Sanofi S.A.; Bristol-Myers Squibb Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.
Product Code: r18476

Table of Contents

1. Executive Summary

2. Small Volume Parenteral Market Characteristics

3. Small Volume Parenteral Market Trends And Strategies

4. Small Volume Parenteral Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Small Volume Parenteral Market Size and Growth

  • 5.1. Global Small Volume Parenteral Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Small Volume Parenteral Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Small Volume Parenteral Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Small Volume Parenteral Market Segmentation

  • 6.1. Global Small Volume Parenteral Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Ampules
  • Vials
  • Prefilled Syringes
  • 6.2. Global Small Volume Parenteral Market, Segmentation By Dose Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Single Dose
  • Multiple Dose
  • 6.3. Global Small Volume Parenteral Market, Segmentation By Indication Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pain Management
  • Cancer Care
  • Malnourishment
  • Gastrointestinal Disorder Or Diarrhea
  • Diabetes
  • Other Indications
  • 6.4. Global Small Volume Parenteral Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Local Anesthetics
  • Vaccines
  • Other Applications
  • 6.5. Global Small Volume Parenteral Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Clinics
  • Ambulatory Surgical Center
  • Other End Users

7. Small Volume Parenteral Market Regional And Country Analysis

  • 7.1. Global Small Volume Parenteral Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Small Volume Parenteral Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Small Volume Parenteral Market

  • 8.1. Asia-Pacific Small Volume Parenteral Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Small Volume Parenteral Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Small Volume Parenteral Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Small Volume Parenteral Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Small Volume Parenteral Market

  • 9.1. China Small Volume Parenteral Market Overview
  • 9.2. China Small Volume Parenteral Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Small Volume Parenteral Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Small Volume Parenteral Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Small Volume Parenteral Market

  • 10.1. India Small Volume Parenteral Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Small Volume Parenteral Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Small Volume Parenteral Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Small Volume Parenteral Market

  • 11.1. Japan Small Volume Parenteral Market Overview
  • 11.2. Japan Small Volume Parenteral Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Small Volume Parenteral Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Small Volume Parenteral Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Small Volume Parenteral Market

  • 12.1. Australia Small Volume Parenteral Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Small Volume Parenteral Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Small Volume Parenteral Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Small Volume Parenteral Market

  • 13.1. Indonesia Small Volume Parenteral Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Small Volume Parenteral Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Small Volume Parenteral Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Small Volume Parenteral Market

  • 14.1. South Korea Small Volume Parenteral Market Overview
  • 14.2. South Korea Small Volume Parenteral Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Small Volume Parenteral Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Small Volume Parenteral Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Small Volume Parenteral Market

  • 15.1. Western Europe Small Volume Parenteral Market Overview
  • 15.2. Western Europe Small Volume Parenteral Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Small Volume Parenteral Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Small Volume Parenteral Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Small Volume Parenteral Market

  • 16.1. UK Small Volume Parenteral Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Small Volume Parenteral Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Small Volume Parenteral Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Small Volume Parenteral Market

  • 17.1. Germany Small Volume Parenteral Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Small Volume Parenteral Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Small Volume Parenteral Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Small Volume Parenteral Market

  • 18.1. France Small Volume Parenteral Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Small Volume Parenteral Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Small Volume Parenteral Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Small Volume Parenteral Market

  • 19.1. Italy Small Volume Parenteral Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Small Volume Parenteral Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Small Volume Parenteral Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Small Volume Parenteral Market

  • 20.1. Spain Small Volume Parenteral Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Small Volume Parenteral Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Small Volume Parenteral Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Small Volume Parenteral Market

  • 21.1. Eastern Europe Small Volume Parenteral Market Overview
  • 21.2. Eastern Europe Small Volume Parenteral Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Small Volume Parenteral Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Small Volume Parenteral Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Small Volume Parenteral Market

  • 22.1. Russia Small Volume Parenteral Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Small Volume Parenteral Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Small Volume Parenteral Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Small Volume Parenteral Market

  • 23.1. North America Small Volume Parenteral Market Overview
  • 23.2. North America Small Volume Parenteral Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Small Volume Parenteral Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Small Volume Parenteral Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Small Volume Parenteral Market

  • 24.1. USA Small Volume Parenteral Market Overview
  • 24.2. USA Small Volume Parenteral Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Small Volume Parenteral Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Small Volume Parenteral Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Small Volume Parenteral Market

  • 25.1. Canada Small Volume Parenteral Market Overview
  • 25.2. Canada Small Volume Parenteral Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Small Volume Parenteral Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Small Volume Parenteral Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Small Volume Parenteral Market

  • 26.1. South America Small Volume Parenteral Market Overview
  • 26.2. South America Small Volume Parenteral Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Small Volume Parenteral Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Small Volume Parenteral Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Small Volume Parenteral Market

  • 27.1. Brazil Small Volume Parenteral Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Small Volume Parenteral Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Small Volume Parenteral Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Small Volume Parenteral Market

  • 28.1. Middle East Small Volume Parenteral Market Overview
  • 28.2. Middle East Small Volume Parenteral Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Small Volume Parenteral Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Small Volume Parenteral Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Small Volume Parenteral Market

  • 29.1. Africa Small Volume Parenteral Market Overview
  • 29.2. Africa Small Volume Parenteral Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Small Volume Parenteral Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Small Volume Parenteral Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Small Volume Parenteral Market Competitive Landscape And Company Profiles

  • 30.1. Small Volume Parenteral Market Competitive Landscape
  • 30.2. Small Volume Parenteral Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. AbbVie Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Bayer AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Sanofi S.A.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Bristol-Myers Squibb Company
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Small Volume Parenteral Market Other Major And Innovative Companies

  • 31.1. Novartis AG
  • 31.2. GlaxoSmithKline plc
  • 31.3. Eli Lilly and Company
  • 31.4. Baxter International Inc.
  • 31.5. Teva Pharmaceutical Industries Ltd.
  • 31.6. Fresenius Kabi AG
  • 31.7. Sun Pharmaceutical Industries Ltd.
  • 31.8. Boehringer Ingelheim GmbH
  • 31.9. Viatris Inc
  • 31.10. Intas Pharmaceuticals Ltd.
  • 31.11. Aurobindo Pharma Limited
  • 31.12. Dr. Reddy's Laboratories Ltd.
  • 31.13. Cipla Limited
  • 31.14. Hikma Pharmaceuticals PLC
  • 31.15. Lupin Limited

32. Global Small Volume Parenteral Market Competitive Benchmarking

33. Global Small Volume Parenteral Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Small Volume Parenteral Market

35. Small Volume Parenteral Market Future Outlook and Potential Analysis

  • 35.1 Small Volume Parenteral Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Small Volume Parenteral Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Small Volume Parenteral Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!